HMBCI is a blind peer reviewed journal and publishes in English: Original articles, Reviews, Mini Reviews, Short Communications, Case Reports, Letters to the Editor and Opinion papers. Ahead-of-print publishing ensures faster processing of fully proof-read, DOI-citable articles.

• Online ISSN: 1868-1891
• Type: Journal
• Language: English
• Publisher: De Gruyter
• First published: March 27, 2010
• Publication Frequency: 4 Issues per Year
• Audience: Researchers and practitioners interested in the topic of HMBCI

• The superfamily of receptors of the different hormones (steroids, polypeptides and related hormones), and co-regulators (activators and repressors);
• Hormones related to the function of growth factors, oncogenes, and cytokines, in normal and neoplastic tissues;
• Enzymes and anti-enzymes involved in the formation and disposition of various hormones in connection with the diseases stated above;
• Hormone signaling and response to hormone therapy;
• Mechanism of cancer cell proliferation under endocrine therapy;
• Resistance to hormone therapy and its mechanism;
• Hormones and the brain and other neuroendocrine organs;
• Hormone replacement therapy;
• Pre-clinical studies to test new molecules in isolated models and in human trials;
• Hormones and the immune system;
• Hormones and the environment;
• Initiation and evolution of diseases related to the mechanism of action of hormones;
• Therapeutic effect of hormones with regard to the method of administration.

Original articles, Reviews, Mini Reviews, Short Communications, Case Reports, Letters to the Editor and Opinion papers

Abstracting and Indexing